<DOC>
	<DOCNO>NCT02699437</DOCNO>
	<brief_summary>The purpose study determine prevalence positive antiphospholipid antibody among woman preeclampsia determine effect antiphospholipid antibody severity preeclampsia obstetric outcome</brief_summary>
	<brief_title>Prevalence Antiphospholipid Antibodies Among Women With Preeclampsia</brief_title>
	<detailed_description>For woman include study , blood sample test anticardiolipin antibody lupus anticoagulant . The clinical detail woman collect review hospital prenatal record . The following clinical characteristic evaluate : maternal age , previous gestation , parity , past family history preeclampsia , gestational age onset preeclampsia , gestational age delivery birth weight . The following pregnancy delivery complication assess : placental insufficiency , intrauterine growth restriction , fetal loss ( stillbirth ) early neonatal death .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Anticardiolipin</mesh_term>
	<mesh_term>Antibodies , Antiphospholipid</mesh_term>
	<criteria>Pregnant woman preeclampsia . Women systemic autoimmune disease . Women active thromboembolic disorder . Women history previous thromboembolic disorder .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Preeclampsia</keyword>
	<keyword>Antiphospholipid Antibodies</keyword>
</DOC>